Breyangi IV injection, manufactured by Bristol-Myers Squibb, contains Risocabutagen Maralucel (YJ code: 4900406X1029, per patient). This medicine is a CAR T-cell therapy, a type of immunotherapy used to treat certain blood cancers.
Breyangi IV injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →